| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/1991 | CA2033928A1 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
| 07/11/1991 | WO1991009967A1 Humanised antibodies |
| 07/11/1991 | WO1991009966A1 Cd4 specific recombinant antibody |
| 07/11/1991 | WO1991009958A2 Method of delivering molecules into eukaryotic cells |
| 07/11/1991 | WO1991009951A2 Recombinant protein c with truncated light chain |
| 07/11/1991 | WO1991009876A1 Radiolabeled proteins for diagnostic or therapeutic use |
| 07/11/1991 | WO1991009870A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/11/1991 | WO1991009865A1 Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof |
| 07/11/1991 | WO1991009840A1 Mercaptocycloacyl aminoacid endopeptidase inhibitors |
| 07/11/1991 | WO1991009641A1 Fibrin sealant delivery method |
| 07/11/1991 | WO1991009627A1 Medicament for treatment of heart failure |
| 07/11/1991 | WO1991009625A1 Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes |
| 07/11/1991 | WO1991009623A1 Diagnosis and treatment of diseases |
| 07/11/1991 | WO1991009620A1 ANTIGENIC sTA PROTEIN PRESENT ON CELLS, CORRESPONDING ANTIBODIES, AND USES THEREOF |
| 07/11/1991 | WO1991009618A1 Combined preparation with thrombolytic action |
| 07/11/1991 | WO1991009617A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/11/1991 | WO1991009615A1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 07/11/1991 | WO1991009613A1 Synthetic peptides as modulators of functional responses of intact cells |
| 07/11/1991 | WO1991009590A1 Pharmaceutical preparation of et18-och3 for intravenous administration |
| 07/11/1991 | WO1991009536A1 A process to correct and optimize the composition of a feed |
| 07/11/1991 | WO1991007967A3 Method of preventing or limiting reperfusion damage |
| 07/11/1991 | CA2072356A1 Diagnosis and treatment of diseases |
| 07/11/1991 | CA2070814A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/10/1991 | WO1991010681A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 07/10/1991 | WO1991010371A1 Acat enzyme inhibiting composition |
| 07/10/1991 | EP0436469A1 Composition and method for the treatment of osteoporosis in mammals |
| 07/10/1991 | EP0436261A1 Combined preparation with thrombolytic effect |
| 07/10/1991 | EP0436189A1 Endothelin atagonistic cyclic pentapeptides |
| 07/10/1991 | EP0436110A1 Pankreatin preparations |
| 07/10/1991 | EP0436086A1 Isolation of alpha-1-antitrypsin from human plasma and construction of a kit useful for detecting alpha 1-antitrypsin levels in blood |
| 07/10/1991 | EP0435996A1 MODIFIED TRANSFORMING GROWTH FACTOR $g(a) OLIGOPEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 07/10/1991 | EP0435957A1 Dna damage-binding factor and uses therefor |
| 07/10/1991 | EP0435948A1 Crf antagonists |
| 07/10/1991 | EP0435946A1 Methods for modifying the binding of cell adhesion receptors. |
| 07/10/1991 | EP0435887A1 Renin inhibitory peptides containing maleamide substituents |
| 07/10/1991 | CN1052896A Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 07/10/1991 | CN1052868A Stabilization and maintenance of nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
| 07/10/1991 | CA2072253A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 07/10/1991 | CA2031984A1 Glidobactin pf-1 peptide antitumor antibiotics |
| 07/09/1991 | WO1991010684A1 Oxidized variants of gm-csf |
| 07/09/1991 | WO1991010446A1 Method for inhibiting follicular maturation |
| 07/09/1991 | WO1991010445A1 Method for increasing fertility in females |
| 07/09/1991 | WO1991010444A1 Method for increasing fertility in males |
| 07/09/1991 | US5030732 Aminoethylphosphinic acid derivatives |
| 07/09/1991 | US5030723 Long-chain glycolipid structure |
| 07/09/1991 | US5030718 Against htlc, in pure form |
| 07/09/1991 | US5030715 Antibacterial agents; immunomodulators; auto immune diseases |
| 07/09/1991 | US5030714 Isolated or synthetic peptide; diagnosis of aids |
| 07/09/1991 | US5030564 Monoclonal antibody specific to the lymphokine LK 2 and its method of production |
| 07/09/1991 | US5030559 Methods and compositions for the identification of metastatic human tumors |
| 07/09/1991 | US5030448 Effective dosage of drug and surface active ethylene oxide-propylene oxide copolymer |
| 07/09/1991 | US5030215 Preparation of fibrinogen/factor XIII precipitate |
| 07/09/1991 | CA2072587A1 Oxidized variants of gm-csf |
| 07/09/1991 | CA2069756A1 Method for inhibiting follicular maturation |
| 07/09/1991 | CA2069755A1 Method for increasing fertility in females |
| 07/09/1991 | CA2069442A1 Method for increasing fertility in males |
| 07/09/1991 | CA1285935C Therapeutic nucleosides |
| 07/09/1991 | CA1285875C Combination therapy using immunotoxins with interleukin-2 |
| 07/09/1991 | CA1285874C Injectable sustained release formulation |
| 07/06/1991 | WO1991009874A1 Novel fibronectin receptor |
| 07/06/1991 | CA2072013A1 Fibronectin receptor |
| 07/06/1991 | CA2033535A1 Method for preparing a dried composition of insulin-like growth factor i |
| 07/05/1991 | WO1991009614A1 GPIbα FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 07/05/1991 | CA2072753A1 Gpi.beta.o fragments and recombinant dna expression vectors |
| 07/04/1991 | WO1991009573A1 Preparation of fibrinogen/factor xiii precipitate |
| 07/04/1991 | DE4000084A1 Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts) Intravenously administered pharmaceutical preparation of ET18-och (down arrow) 3 (down arrow) |
| 07/04/1991 | CA2072371A1 Preparation of fibrinogen/factor xiii precipitate |
| 07/03/1991 | WO1991009949A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 07/03/1991 | EP0435617A1 Bovine myogenic factor gene |
| 07/03/1991 | EP0435503A1 Improvements in or relating to gylcopeptide derivatives |
| 07/03/1991 | EP0435436A2 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
| 07/03/1991 | EP0435059A1 Retroviral protease inhibitors |
| 07/03/1991 | EP0434979A1 Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide |
| 07/03/1991 | EP0434909A2 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
| 07/03/1991 | EP0434751A1 A malaria antigen |
| 07/03/1991 | EP0434747A1 Viral vaccines |
| 07/03/1991 | EP0434744A1 Serum immunoregulatory polypeptide and uses therefor. |
| 07/03/1991 | EP0434722A1 New pentapeptide and a process for the preparation thereof |
| 07/03/1991 | EP0434721A1 Viral nucleotide sequences |
| 07/03/1991 | EP0434718A1 Peptide compounds |
| 07/03/1991 | EP0434685A1 Gram-negative bacterial endotoxin blocking monoclonal antibodies |
| 07/03/1991 | EP0425507A4 Compositions and methods for treating skin conditions and promoting wound healing |
| 07/03/1991 | EP0398925A4 Growth inhibiting agent and the use thereof |
| 07/03/1991 | EP0151128B1 Monoclonal antibodies reactive with endotoxin core |
| 07/03/1991 | CN1052608A Bcrfl proteins as inhibitors of interferon-gamma |
| 07/03/1991 | CN1052607A Cell cycle-dependent regulation of phosphorylation of human retion blastoma gene product |
| 07/02/1991 | US5028694 Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella |
| 07/02/1991 | US5028627 Controlling blood pressure during chemotherapy |
| 07/02/1991 | US5028626 Peptides with pharmaceutical activity |
| 07/02/1991 | US5028599 Injecting An Ethylene Oxide-Propylene Oxide Surfactant |
| 07/02/1991 | US5028593 Tuftsin analogs |
| 07/02/1991 | US5028592 Oligopeptides or polypeptides containing the sequence lysine-proline-valine |
| 07/02/1991 | US5028591 Administering a dosage of somatotropin and luteotropin; viricides, bactericides, fungicides |
| 07/02/1991 | US5028590 Derivatives of A54145 cyclic peptides |
| 07/02/1991 | US5028589 Aliments For Dietetic Or Therapeutic Nutrition |
| 07/02/1991 | US5028588 Blood substitutes |
| 07/02/1991 | US5028587 Containing arg-b31 and/or arg2-(b31-32) human insulin; antidiabetic agents |
| 07/02/1991 | US5028586 Eliminating some or all of the acid containing side chains by esterification or replacement of glutamic acid residues with glutamine, prolonged action |
| 07/02/1991 | US5028534 DNA clones of human placental plasminogen activator inhibitor |
| 07/02/1991 | US5028430 Delivery systems for the controlled administration of LHRH analogs |